99 related articles for article (PubMed ID: 29179460)
1. GSK-3β phosphorylation-dependent degradation of ZNF281 by β-TrCP2 suppresses colorectal cancer progression.
Zhu Y; Zhou Q; Zhu G; Xing Y; Li S; Ren N; Liu T; Zhu A; Bai Y; Piao D
Oncotarget; 2017 Oct; 8(51):88599-88612. PubMed ID: 29179460
[TBL] [Abstract][Full Text] [Related]
2. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization.
Ding Q; He X; Hsu JM; Xia W; Chen CT; Li LY; Lee DF; Liu JC; Zhong Q; Wang X; Hung MC
Mol Cell Biol; 2007 Jun; 27(11):4006-17. PubMed ID: 17387146
[TBL] [Abstract][Full Text] [Related]
3. The cross talk of two family members of β-TrCP in the regulation of cell autophagy and growth.
Cui D; Dai X; Shu J; Ma Y; Wei D; Xiong X; Zhao Y
Cell Death Differ; 2020 Mar; 27(3):1119-1133. PubMed ID: 31406304
[TBL] [Abstract][Full Text] [Related]
4. β-TrCP1 facilitates cell cycle checkpoint activation, DNA repair, and cell survival through ablation of β-TrCP2 in response to genotoxic stress.
Islam S; Dutta P; Sahay O; Santra MK
J Biol Chem; 2021; 296():100511. PubMed ID: 33676897
[TBL] [Abstract][Full Text] [Related]
5. S6 Kinase- and β-TrCP2-Dependent Degradation of p19Arf Is Required for Cell Proliferation.
Nakagawa T; Araki T; Nakagawa M; Hirao A; Unno M; Nakayama K
Mol Cell Biol; 2015 Oct; 35(20):3517-27. PubMed ID: 26240281
[TBL] [Abstract][Full Text] [Related]
6. The role of {beta}-TrCP1 and {beta}-TrCP2 in circadian rhythm generation by mediating degradation of clock protein PER2.
Ohsaki K; Oishi K; Kozono Y; Nakayama K; Nakayama KI; Ishida N
J Biochem; 2008 Nov; 144(5):609-18. PubMed ID: 18782782
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer.
Cheng LZ; Huang DL; Tang ZR; Zhang JH; Xiong T; Zhou C; Zhang NX; Fu R; Cheng YX; Wu ZQ
Br J Pharmacol; 2023 Dec; 180(23):3071-3091. PubMed ID: 37461816
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.
Olianas MC; Dedoni S; Onali P
Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805
[TBL] [Abstract][Full Text] [Related]
9. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
Khor TO; Gul YA; Ithnin H; Seow HF
Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K
Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase 3beta phosphorylates p21WAF1/CIP1 for proteasomal degradation after UV irradiation.
Lee JY; Yu SJ; Park YG; Kim J; Sohn J
Mol Cell Biol; 2007 Apr; 27(8):3187-98. PubMed ID: 17283049
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
15. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32.
Al-Fageeh M; Li Q; Dashwood WM; Myzak MC; Dashwood RH
Oncogene; 2004 Jun; 23(28):4839-46. PubMed ID: 15064718
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta suppresses tumor necrosis factor-alpha expression in cardiomyocytes during lipopolysaccharide stimulation.
Shen E; Fan J; Peng T
J Cell Biochem; 2008 May; 104(1):329-38. PubMed ID: 18027881
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
[TBL] [Abstract][Full Text] [Related]
20. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y
Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
